Early research (Phase 1)Study completedNCT02324582What this trial is testingMK-3475/BCG in High Risk Superficial Bladder CancerWho this might be right forBladder Cancer Southern Illinois University 18
Large-scale testing (Phase 3)Looking for participantsNCT06441110What this trial is testingMulticenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder CancerWho this might be right forUrinary Bladder NeoplasmsBCG VaccineImmunotherapy, Active+3 more Fujian Medical University Union Hospital 76
Large-scale testing (Phase 3)Ended earlyNCT04149574What this trial is testingA Study Comparing the Efficacy and Safety of Nivolumab in Combination With Bacillus Calmette-Guerin (BCG) Versus BCG Alone in Participants With High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC)Who this might be right forUrinary Bladder Neoplasms Bristol-Myers Squibb 13
Large-scale testing (Phase 3)Looking for participantsNCT06919965What this trial is testingEvaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder CancerWho this might be right forNon-Muscle Invasive Bladder Neoplasms Janssen Research & Development, LLC 220
Large-scale testing (Phase 3)Looking for participantsNCT06525571What this trial is testingOutcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light ResectionWho this might be right forBladder Cancer Johns Hopkins University 200
Not applicableLooking for participantsNCT07036731What this trial is testingA Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth SequencingWho this might be right forNon Muscle Invasive Bladder Cancer The First Affiliated Hospital with Nanjing Medical University 428
Testing effectiveness (Phase 2)Study completedNCT00696579What this trial is testingBacillus of Calmette and Guerin (BCG) Versus Gemcitabine For Intravesical Therapy In High Risk Superficial Bladder CancerWho this might be right forBladder Cancer University Of Perugia 64
Not applicableLooking for participantsNCT06889623What this trial is testingImmediate Chemotherapy Following Resection for High-Risk Non-Muscle-Invasive Bladder CancerWho this might be right forNMIBC Changhai Hospital 72
Testing effectiveness (Phase 2)Study completedNCT04593862What this trial is testingBladder Cancer and ExeRcise Training During IntraVesical ThErapyWho this might be right forBladder Cancer University of Alberta 25
Testing effectiveness (Phase 2)UnknownNCT05418309What this trial is testingTilelizumab Combined With Nab-Paclitaxel for High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma Which is Not Completely Resectable: a Multi-center StudyWho this might be right forHigh-Risk Non-Muscle Invasive Bladder Urothelial Carcinoma Tianjin Medical University Second Hospital 63
Large-scale testing (Phase 3)Study completedNCT02773849What this trial is testingADSTILADRIN (=INSTILADRIN) in Patients With High-Grade, Bacillus Calmette-Guerin (BCG) Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)Who this might be right forSuperficial Bladder Cancer Ferring Pharmaceuticals 157
Early research (Phase 1)Not Yet RecruitingNCT07783815What this trial is testingEvaluate the Efficacy and Safety of Intravesical Instillation of Disitamab Vedotin Combined With Toripalimab in Patients With HER2-Positive High-Risk Non-Muscle Invasive Bladder Cancer Who Are BCG-Naïve or Have BCG FailureWho this might be right forBladder Cancer Xiangya Hospital of Central South University 20
Not applicableLooking for participantsNCT05123625What this trial is testingPrognostic Effect of Whether Doing PLND During RC for High-risk NMIBCWho this might be right forBladder Cancer The First Affiliated Hospital with Nanjing Medical University 200
Testing effectiveness (Phase 2)Study completedNCT00794950What this trial is testingBacillus Calmette-Guerin Followed by Sunitinib for the Treatment of High Risk Non-muscle Invasive Lower Urinary Tract Urothelial CarcinomaWho this might be right forUrinary Tract Urothelial Carcinoma University of Michigan 43
Early research (Phase 1)UnknownNCT06427291What this trial is testingClinical Study of T3011 Intravesical Instillation for Treatment of NMIBC PatientsWho this might be right forBladder Cancer Fudan University 20
Not applicableNot Yet RecruitingNCT07231809What this trial is testingHyperthermic Intravesical Chemotherapy (HIVEC) in BCG-Non-Responsive High-Grade NMIBC PatientsWho this might be right forNon Muscle Invasive Bladder CancerBladder CancerCarcinoma in Situ of Bladder+2 more AC.TA. S.r.l. 50
Not applicableStudy completedNCT04726735What this trial is testingEvaluation of PD-L1 Expression and Immune Infiltration in High-risk Non Muscle Invasive Bladder CancerWho this might be right forBladder Cancer University Hospital, Bordeaux 100
Not applicableLooking for participantsNCT07130578What this trial is testingThe Guiding Value of Liquid Biopsy Based on Urinary Tumor DNA/RNA in the Second Transurethral Resection of High-risk Non-muscle Invasive Bladder CancerWho this might be right forBladder CancerLiquid Biopsy Tianjin Medical University Second Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT07646145What this trial is testingDisitamab Vedotin Plus Intravesical Mitomycin C in HER2-Expressing Intermediate- to High-Risk Non-Muscle-Invasive Bladder CancerWho this might be right forNon-Muscle-Invasive Bladder Cancer (NMIBC) Shanxi Province Cancer Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06255964What this trial is testingIAP0971 in Combination With Bacillus Calmette Guerin in High Risk Non-muscular Invasive Bladder CancerWho this might be right forBladder Cancer SUNHO（China）BioPharmaceutical CO., Ltd. 236